Parkinson’s disease (PD) belongs to a class of neurodegenerative diseases that affect the patient’s speech, motor, and cognitive capabilities. All three deÞcits affect the multimodal communication channels of speech and gesture. We present a study on the changes in speech pause patterns and gesture holds before and after treatment. We present the results of a pilot study of two Idiopathic PD pa...

Parkinson’s disease (PD) is a chronic, neurodegenerative condition resulting in various motor impairments, including speech disorders. However, at the height of coronavirus 2019 pandemic, patient with PD could not access traditional in-person neurorehabilitation care. This case report highlights feasibility telerehabilitation to deliver therapy over distance using available resources developing...

This critical review examines the long term (12 and 24 month) effectiveness of LSVT on improving speech and voice production in patients with Parkinson’s disease. Study designs reviewed included two randomized control trial studies, two single subject multiple baseline studies, and one single group pre-posttest study. Results provided suggestive evidence supporting the long term effectiveness o...

The bilingual voice: Vocal characteristics when speaking two languages across speech tasks Binna Lee & Diana Van Lancker Sidtis To cite this article: Binna Lee & Diana Van Lancker Sidtis (2017): The bilingual voice: Vocal characteristics when speaking two languages across speech tasks, Speech, Language and Hearing, DOI: 10.1080/2050571X.2016.1273572 To link to this article: http://dx.doi.org/10...

LSVT LOUD (Lee Silverman Voice Treatment) is efficacious in the treatment of speech disorders in idiopathic Parkinson's disease (IPD), particularly hypophonia. Functional imaging in patients with IPD has shown abnormalities in several speech regions and changes in these areas immediately following treatment. This study serves to extend the analysis by correlating changes of regional neural acti...

OBJECTIVE Parkinsonian patients usually present speech impairment. The aim of this study was to verify the influence of levodopa and of the adapted Lee Silverman Vocal Treatment® method on prosodic parameters employed by parkinsonian patients. METHOD Ten patients with idiopathic Parkinson's disease using levodopa underwent recording of utterances produced in four stages: expressing attitudes ...